by adminTorusBrand | Mar 1, 2016 | Company News, Kannalife Sciences
U.S. Phyto-Medical Company Clears Regulatory Hurdle in Its Ongoing Feasibility Study With Catalent Pharma Solutions for the Development of a Novel Cannabinoid Therapeutic Agent to Treat HE and CTE SAN DIEGO, March 01, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc....
by adminTorusBrand | Feb 26, 2016 | Company News, Kannalife Sciences
Reuters Reports That Kannalife is Considering an Initial Public Offering This Year to Fund Development of a Cannabis-Based Treatment for a Brain Disorder That Affects 200,000 Americans SAN DIEGO, Feb. 26, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA)...
by adminTorusBrand | Feb 22, 2016 | Company News, Kannalife Sciences, Press Releases
Kannalife Sciences, Inc., a Phyto-Medical Company™ has found through its research that KLS-13019 is 50x More Potent and Over 400-Fold Safer Than CBD SAN DIEGO, CA – February 18, 2016 – Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce that the Company’s...
by adminTorusBrand | Feb 15, 2016 | Company News, Kannalife Sciences
Multiple activists and advocacy groups have been calling on the NFL to loosen their rules regarding medical marijuana, claiming that it could be the key to preventing the sports extinction. A bold claim, no doubt, but corroborated by lists of former NFL stars who have...
by adminTorusBrand | Jan 5, 2016 | Education, Kannalife Sciences, Scientific Research
The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these...